Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma
View/
Volume
46
Pagination
536 - 542
DOI
10.1016/j.oraloncology.2010.03.022
Journal
ORAL ONCOL
Issue
ISSN
1368-8375
